Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07548047

Effectiveness of Dextrose Pleurodesis for the Management of Post-Operative Air Leak

A common complication following lung resection surgery is the presence of a post-operative air leak. This occurs when the resected lung tissue does not seal adequately, resulting in continued leakage of air from the lung. For most patient, an air leak will self-resolve by maintaining a drainage catheter in the chest for a prolonged period. However, for some patients, additional measures are required to help seal the affected tissue. Known strategies for managing post-operative air leak include placing one-way valves, surgical revision, and chemical pleurodesis. Chemical pleurodesis involves injecting an irritant through the chest drainage catheter to promote sealing of the leaking lung tissue. While many agents exist for chemical pleurodesis, a relatively new method for treating an air leak is by using dextrose solution. Dextrose is appealing due to low cost and availability. Dextrose solution has shown some efficacy in other countries and undergone Phase 1 clinical investigation in Canada to show its safety and dosing recommendations. In this study, our aim is to compare the effectiveness of using dextrose solution for treating post-operative air leak compared to usual care with chest tube drainage alone.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 2

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adult patients who have undergone lung resection
  • Persistent post-operative air leak >24 hours after surgery with air leak >20 mL/min

Exclusion criteria

  • pregnant patients
  • incarcerated patients
  • patients with early post-operative complications
  • hemodynamic instability
  • need for mechanical ventilator support
  • high volume chest tube output (>750 mL over 24h)

Treatment and study plan

50% Dextrose Pleurodesis

Drug

A one time intrapleural instillation of 150mL of dextrose will be administered following analgesia with 10mL lidocaine

Other names: Dextrose, D50

Standard of Care Chest Drainage

Other

maintenance of post operative pulmonary drain without additional intervention

Other names: Standard of Care

Primary outcomes

  1. Time to air leak resolution

    Time frame: from randomization to resolution of air leak (<20 mL/min), assessed up to 30 days

    air leak <20mL/min as measured by digital tracking atrium

Secondary outcomes

  1. Chest tube duration

    Time frame: from randomization until chest tube removal, assessed up to 30 days

    time until chest tube removal

  2. Hospital Length of Stay

    Time frame: from randomization until hospital discharge, assessed up to 30 days

    time until patient discharge

  3. Adverse Events

    Time frame: from randomization through 30 days post-procedure

    occurrence of complications including respiratory failure, pneumonia, and fever

Study contacts

Contact information is provided by the study sponsor or research team.

Jacob F Woodroof, MD

CONTACT

[email protected]

215-955-6996

Sponsors and collaborators

Lead sponsor

Thomas Jefferson University

Other

Registry information

Official study title

Dextrose Pleurodesis Versus Standard of Care for the Management of Post-Operative Air Leak: A Single Center Prospective Trial

Important dates

Study start
2026
Primary completion
2028
Study completion
2029
First posted
Apr 23, 2026
Registry last updated
Apr 23, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.